EUVIMEDEUVIMED entdecken
Crossref

820P Leronlimab (LRM) in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab (BEV) in metastatic colorectal cancer (mCRC): The phase 2 CLOVER study

B. Weinberg, A. Baron, A. Chaudhry, L.L. Tenner, N. Vijayvergia, M.F. Driscoll, M.S. Noel, H. Rui, D.L. Adams, A.B. Duffy, R.G. Pestell, P. Vittner und 3 weitere

Annals of Oncology · 2026-12 · 37 · S697-S698

DOI: 10.1016/j.annonc.2026.08.1007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Oncology, 2026-12. Verfasst von B. Weinberg und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Weinberg, B., Baron, A., Chaudhry, A., Tenner, L., Vijayvergia, N., Driscoll, M., Noel, M., Rui, H., Adams, D., Duffy, A., Pestell, R., Vittner, P., Meidling, J., Lalezari, J., & Kasi, P. (2026). 820P Leronlimab (LRM) in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab (BEV) in metastatic colorectal cancer (mCRC): The phase 2 CLOVER study. Annals of Oncology, 37, S697-S698. https://doi.org/10.1016/j.annonc.2026.08.1007

Vancouver

Weinberg B, Baron A, Chaudhry A, Tenner L, Vijayvergia N, Driscoll M, et al. 820P Leronlimab (LRM) in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab (BEV) in metastatic colorectal cancer (mCRC): The phase 2 CLOVER study. Annals of Oncology. 2026;37:S697-S698. doi:10.1016/j.annonc.2026.08.1007

BibTeX
@article{Weinberg2026,
  author = {Weinberg, B. and Baron, A. and Chaudhry, A. and Tenner, L.L. and Vijayvergia, N. and Driscoll, M.F. and Noel, M.S. and Rui, H. and Adams, D.L. and Duffy, A.B. and Pestell, R.G. and Vittner, P. and Meidling, J. and Lalezari, J.P. and Kasi, P.M.},
  title = {820P Leronlimab (LRM) in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab (BEV) in metastatic colorectal cancer (mCRC): The phase 2 CLOVER study},
  journal = {Annals of Oncology},
  year = {2026},
  volume = {37},
  pages = {S697--S698},
  doi = {10.1016/j.annonc.2026.08.1007}
}
Kostenlos starten →